Annual Working Capital
$231.18 M
+$18.55 M+8.72%
December 31, 2024
Summary
- As of March 10, 2025, KNSA annual working capital is $231.18 million, with the most recent change of +$18.55 million (+8.72%) on December 31, 2024.
- During the last 3 years, KNSA annual working capital has risen by +$79.56 million (+52.47%).
- KNSA annual working capital is now -23.30% below its all-time high of $301.40 million, reached on December 31, 2020.
Performance
KNSA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$231.18 M
+$15.83 M+7.35%
December 31, 2024
Summary
- As of March 10, 2025, KNSA quarterly working capital is $231.18 million, with the most recent change of +$15.83 million (+7.35%) on December 31, 2024.
- Over the past year, KNSA quarterly working capital has stayed the same.
- KNSA quarterly working capital is now -34.61% below its all-time high of $353.52 million, reached on September 30, 2020.
Performance
KNSA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
KNSA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.7% | 0.0% |
| 3 y3 years | +52.5% | +52.5% |
| 5 y5 years | +8.1% | +8.1% |
KNSA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +52.5% | at high | +69.5% |
| 5 y | 5-year | -23.3% | +52.5% | -34.6% | +69.5% |
| alltime | all time | -23.3% | +679.1% | -34.6% | +679.1% |
Kiniksa Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $231.18 M(+8.7%) | $231.18 M(+7.4%) |
| Sep 2024 | - | $215.35 M(-0.6%) |
| Jun 2024 | - | $216.73 M(+5.0%) |
| Mar 2024 | - | $206.38 M(-2.9%) |
| Dec 2023 | $212.63 M(+8.5%) | $212.63 M(+4.9%) |
| Sep 2023 | - | $202.64 M(+2.1%) |
| Jun 2023 | - | $198.57 M(+1.9%) |
| Mar 2023 | - | $194.91 M(-0.6%) |
| Dec 2022 | $195.99 M(+29.3%) | $195.99 M(+5.8%) |
| Sep 2022 | - | $185.32 M(+35.9%) |
| Jun 2022 | - | $136.39 M(-8.1%) |
| Mar 2022 | - | $148.40 M(-2.1%) |
| Dec 2021 | $151.62 M | $151.62 M(-17.2%) |
| Sep 2021 | - | $183.09 M(-11.1%) |
| Jun 2021 | - | $206.03 M(-14.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $240.11 M(-20.3%) |
| Dec 2020 | $301.40 M(+41.0%) | $301.40 M(-14.7%) |
| Sep 2020 | - | $353.52 M(+44.9%) |
| Jun 2020 | - | $243.94 M(+25.9%) |
| Mar 2020 | - | $193.71 M(-9.4%) |
| Dec 2019 | $213.80 M(-21.2%) | $213.80 M(-11.2%) |
| Sep 2019 | - | $240.78 M(-9.6%) |
| Jun 2019 | - | $266.28 M(-10.7%) |
| Mar 2019 | - | $298.06 M(+9.9%) |
| Dec 2018 | $271.20 M(+813.9%) | $271.20 M(-13.5%) |
| Sep 2018 | - | $313.51 M(-8.0%) |
| Jun 2018 | - | $340.73 M(+67.7%) |
| Mar 2018 | - | $203.19 M(+584.7%) |
| Dec 2017 | $29.67 M(-45.1%) | $29.67 M |
| Dec 2016 | $54.03 M | - |
FAQ
- What is Kiniksa Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual working capital year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly working capital year-on-year change?
What is Kiniksa Pharmaceuticals annual working capital?
The current annual working capital of KNSA is $231.18 M
What is the all time high annual working capital for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual working capital is $301.40 M
What is Kiniksa Pharmaceuticals annual working capital year-on-year change?
Over the past year, KNSA annual working capital has changed by +$18.55 M (+8.72%)
What is Kiniksa Pharmaceuticals quarterly working capital?
The current quarterly working capital of KNSA is $231.18 M
What is the all time high quarterly working capital for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly working capital is $353.52 M
What is Kiniksa Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, KNSA quarterly working capital has changed by $0.00 (0.00%)